Discovery Inc is currently reviewing an opportunity to obtai

Discovery, Inc is currently reviewing an opportunity to obtain a compound containing 20 mg of hydrocodone and 400 mg of acetaminophen that is currently in Phase II development for the treatment of moderate to moderately severe pain. This controlled release hydrocodone/acetaminophen will be the first extended-release opioid combination product to offer 12 hours of sustained pain relief with a single dose. Discovery management would like to determine if this new compound would address any unmet needs in the moderate to moderately severe pain marketplace. (please answer both questions)

1. What questions do you need to answer and/or data to obtain or analyze before you can decide if you are to recommend that your company consider this new compound for acquisition? 2. Based on your questions and data needs, please outline your market research objectives and data collection approach(es) to answer these questions?

Solution

1. The possible questions that need to be answered may be:

2. Market research objective will be the analysis of past perforance of these drugs and their side effects. Depending on the positive and negative effects of the drug in different patients, the future performance can be enhanced by improving the standards. data can be collected from the medical stores, drug manufacturing companies about quantity, from the doctors for the prescription of medicine and its performance in patients. Annual records of surveys and data analysis can also be used to find trend in the drugs acceptance in market and patients.